EverSource Wealth Advisors’s Orthofix Medical OFIX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.45K Sell
596
-356
-37% -$3.92K ﹤0.01% 3245
2026
Q1
$10.9K Sell
952
-123
-11% -$1.62K ﹤0.01% 2868
2025
Q4
$16.3K Sell
1,075
-127
-11% -$1.94K ﹤0.01% 2520
2025
Q3
$17.6K Buy
1,202
+294
+32% +$3.86K ﹤0.01% 2457
2025
Q2
$10.1K Buy
908
+795
+704% +$9.85K ﹤0.01% 2798
2025
Q1
$1.84K Buy
113
+94
+495% +$1.65K ﹤0.01% 2961
2024
Q4
$332 Buy
+19
New +$330 ﹤0.01% 3316
2023
Q4
Sell
-58
Closed -$746 2714
2023
Q3
$746 Buy
+58
New +$1.04K ﹤0.01% 2316
2023
Q1
Sell
-49
Closed -$1.01K 2485
2022
Q4
$1.01K Sell
49
-469
-91% -$8.27K ﹤0.01% 2085
2022
Q3
$10K Buy
+518
New +$11.6K ﹤0.01% 1141
2022
Q2
Sell
-242
Closed -$8K 1840
2022
Q1
$8K Buy
+242
New +$7.78K ﹤0.01% 1087

Other funds holding OFIX

EverSource Wealth Advisors's OFIX Position: Q2 2026 in Review

EverSource Wealth Advisors reduced its Orthofix Medical (OFIX) stake by 37% in Q2 2026, selling an estimated $3.92K and leaving 596 shares worth $5.45K. The position accounts for ﹤0.01% of the portfolio, ranked #3245.

EverSource Wealth Advisors first reported a position in OFIX in Q1 2022 and has held it in 11 quarters since. The position peaked at $17.6K in Q3 2025. 143 funds tracked by Wall St. Rank hold OFIX as of Q2 2026.

  • EverSource Wealth Advisors held 596 shares of Orthofix Medical worth $5.45K as of Q2 2026.
  • EverSource Wealth Advisors sold 356 Orthofix Medical shares in Q2 2026, an estimated $3.92K.
  • Orthofix Medical made up ﹤0.01% of EverSource Wealth Advisors's portfolio in Q2 2026, its #3245 holding.
  • EverSource Wealth Advisors first reported a position in Orthofix Medical in Q1 2022 and has held it in 11 quarters since.
  • EverSource Wealth Advisors's Orthofix Medical position peaked at $17.6K in Q3 2025.
  • 143 funds tracked by Wall St. Rank held Orthofix Medical as of Q2 2026.

Based on EverSource Wealth Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.